GSK plc (NYSE:GSK)
| 33.78 Delayed Data As of 4:00pm ET |  -0.215 / -0.63%Today’s Change | 28.47 Today|||52-Week Range 43.70 | -6.10% Year-to-Date |
Latest GSK News | Press Releases
| Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication Nov 25 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights Wells Fargo, Honeywell International, Northrop Grumman, The Travelers Companies and GSK Nov 18 / Zacks.com - Paid Partner Content |
| GSK to Withdraw Blenrep From U.S. Market on FDA Request Nov 23 / Zacks.com - Paid Partner Content | Top Stock Reports for Wells Fargo, Honeywell & Northrop Grumman Nov 17 / Zacks.com - Paid Partner Content |
| Gilead (GILD) Outperforms YTD: Will It Retain the Momentum? Nov 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 33.99 |
| Today’s open | 33.76 |
| Day’s range | 33.71 - 34.04 |
| Volume | 7,149,311 |
| Average volume (3 months) | 6,638,334 |
| Market cap | $69.1B |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -18.64% |
| Earnings growth (this year) | +1.48% |
| Earnings growth (next 5 years) | +9.30% |
| Revenue growth (last year) | +7.30% |
| P/E ratio | 13.0 |
| Price/Sales | 2.38 |
| Price/Book | 3.34 |
Competitors
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | February 1, 2023 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $46.9B |
| Annual profit (last year) | $6.0B |
| Net profit margin | 12.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
